Cargando…
ENDOCRINOLOGY IN THE TIME OF COVID-19: Diagnosis and management of gestational diabetes mellitus
The COVID-19 pandemic has required rapid transformation and adaptation of healthcare services. Women with gestational diabetes mellitus (GDM) are one of the largest high-risk groups accessing antenatal care. In reformulating the care offered to those with GDM, there is a need to balance the sometime...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938017/ https://www.ncbi.nlm.nih.gov/pubmed/32454456 http://dx.doi.org/10.1530/EJE-20-0401 |
_version_ | 1783661514727620608 |
---|---|
author | Thangaratinam, Shakila Cooray, Shamil D Sukumar, Nithya Huda, Mohammed S B Devlieger, Roland Benhalima, Katrien McAuliffe, Fionnuala Saravanan, Ponnusamy Teede, Helena J |
author_facet | Thangaratinam, Shakila Cooray, Shamil D Sukumar, Nithya Huda, Mohammed S B Devlieger, Roland Benhalima, Katrien McAuliffe, Fionnuala Saravanan, Ponnusamy Teede, Helena J |
author_sort | Thangaratinam, Shakila |
collection | PubMed |
description | The COVID-19 pandemic has required rapid transformation and adaptation of healthcare services. Women with gestational diabetes mellitus (GDM) are one of the largest high-risk groups accessing antenatal care. In reformulating the care offered to those with GDM, there is a need to balance the sometimes competing requirement of lowering the risk of direct viral transmission against the potential adverse impact of service changes. We suggest pragmatic options for screening of GDM in a pandemic setting based on blood tests, and risk calculators applied to underlying risk factors. Alternative models for antenatal care provision for women with GDM, including targeting high-risk groups, early lifestyle interventions and remote monitoring are provided. Testing options and their timing for postpartum screening in women who had GDM are also considered. Our suggestions are only applicable in a pandemic scenario, and usual guidelines and care pathways should be re-implemented as soon as possible and appropriate. |
format | Online Article Text |
id | pubmed-7938017 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-79380172021-03-11 ENDOCRINOLOGY IN THE TIME OF COVID-19: Diagnosis and management of gestational diabetes mellitus Thangaratinam, Shakila Cooray, Shamil D Sukumar, Nithya Huda, Mohammed S B Devlieger, Roland Benhalima, Katrien McAuliffe, Fionnuala Saravanan, Ponnusamy Teede, Helena J Eur J Endocrinol Clinical Practice Guidance The COVID-19 pandemic has required rapid transformation and adaptation of healthcare services. Women with gestational diabetes mellitus (GDM) are one of the largest high-risk groups accessing antenatal care. In reformulating the care offered to those with GDM, there is a need to balance the sometimes competing requirement of lowering the risk of direct viral transmission against the potential adverse impact of service changes. We suggest pragmatic options for screening of GDM in a pandemic setting based on blood tests, and risk calculators applied to underlying risk factors. Alternative models for antenatal care provision for women with GDM, including targeting high-risk groups, early lifestyle interventions and remote monitoring are provided. Testing options and their timing for postpartum screening in women who had GDM are also considered. Our suggestions are only applicable in a pandemic scenario, and usual guidelines and care pathways should be re-implemented as soon as possible and appropriate. Oxford University Press 2020-08-01 /pmc/articles/PMC7938017/ /pubmed/32454456 http://dx.doi.org/10.1530/EJE-20-0401 Text en © 2020 The authors https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by/4.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Clinical Practice Guidance Thangaratinam, Shakila Cooray, Shamil D Sukumar, Nithya Huda, Mohammed S B Devlieger, Roland Benhalima, Katrien McAuliffe, Fionnuala Saravanan, Ponnusamy Teede, Helena J ENDOCRINOLOGY IN THE TIME OF COVID-19: Diagnosis and management of gestational diabetes mellitus |
title | ENDOCRINOLOGY IN THE TIME OF COVID-19: Diagnosis and management of gestational diabetes mellitus |
title_full | ENDOCRINOLOGY IN THE TIME OF COVID-19: Diagnosis and management of gestational diabetes mellitus |
title_fullStr | ENDOCRINOLOGY IN THE TIME OF COVID-19: Diagnosis and management of gestational diabetes mellitus |
title_full_unstemmed | ENDOCRINOLOGY IN THE TIME OF COVID-19: Diagnosis and management of gestational diabetes mellitus |
title_short | ENDOCRINOLOGY IN THE TIME OF COVID-19: Diagnosis and management of gestational diabetes mellitus |
title_sort | endocrinology in the time of covid-19: diagnosis and management of gestational diabetes mellitus |
topic | Clinical Practice Guidance |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938017/ https://www.ncbi.nlm.nih.gov/pubmed/32454456 http://dx.doi.org/10.1530/EJE-20-0401 |
work_keys_str_mv | AT thangaratinamshakila endocrinologyinthetimeofcovid19diagnosisandmanagementofgestationaldiabetesmellitus AT coorayshamild endocrinologyinthetimeofcovid19diagnosisandmanagementofgestationaldiabetesmellitus AT sukumarnithya endocrinologyinthetimeofcovid19diagnosisandmanagementofgestationaldiabetesmellitus AT hudamohammedsb endocrinologyinthetimeofcovid19diagnosisandmanagementofgestationaldiabetesmellitus AT devliegerroland endocrinologyinthetimeofcovid19diagnosisandmanagementofgestationaldiabetesmellitus AT benhalimakatrien endocrinologyinthetimeofcovid19diagnosisandmanagementofgestationaldiabetesmellitus AT mcauliffefionnuala endocrinologyinthetimeofcovid19diagnosisandmanagementofgestationaldiabetesmellitus AT saravananponnusamy endocrinologyinthetimeofcovid19diagnosisandmanagementofgestationaldiabetesmellitus AT teedehelenaj endocrinologyinthetimeofcovid19diagnosisandmanagementofgestationaldiabetesmellitus |